remove_red_eye 467 Views
#Cardiology #Diabetes and Endocrinology #Internal Medicine #Neurology
A new consensus update on the diagnosis and treatment of acromegaly comorbidities emphasizes aggressive treatment of cardiovascular, endocrine, metabolic and other conditions, including sleep apnea and bone and joint disorders.
"The most important message is that acromegaly is associated with very high, common comorbidities - mainly cardiovascular, hypertension, diabetes, sleep apnea and rheumatologic - and the cause of death in these patients is really due to exacerbations of those comorbidities," Dr. Shlomo Melmed of Cedars-Sinai Medical Center in Los Angeles stated. The update was published online October 13 in the Journal of Clinical Endocrinology and Metabolism.